Biomarkers in bronchopulmonary dysplasia

Paediatric Respiratory Reviews

Volumn 14, Issue 3, 2013, Pages 173-179

  Bhandari, Anita ^a   Bhandari, Vineet ^b  

^a Farmington   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Growth factors; Lung; Newborn; Premature

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA FETOPROTEIN; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; CHEMOKINE; CHORIONIC GONADOTROPIN; CYTOKINE; ENDOSTATIN; ESTRIOL; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; LEUKOTRIENE E4; PROSTAGLANDIN F2 ALPHA; PROTEINASE; PROTEINASE INHIBITOR; SCLEROPROTEIN;

GENETIC MARKER; HISTOPATHOLOGY; HUMAN; INFANT DISEASE; INFLAMMATION; LUNG DYSPLASIA; MATERNAL SERUM; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TRACHEAL ASPIRATION PROCEDURE; UMBILICAL CORD BLOOD; URINE LEVEL;

CYTOKINES; GROWTH FACTORS; LUNG; NEWBORN; PREMATURE;

ANIMALS; BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; CYTOKINES; DISEASE MODELS, ANIMAL; FETAL BLOOD; GENE-ENVIRONMENT INTERACTION; HUMANS; INFANT;

EID: 84881551784     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2013.02.008     Document Type: Review

References (73)

1. Bhandari A., Bhandari V. "New" Bronchopulmonary Dysplasia: A clinical review. Clin Pulm Med 2011, 18:137-143.
2. Trembath A., Laughon M.M. Predictors of bronchopulmonary dysplasia. Clin Perinatol 2012, 39:585-601. Epub 2012/09/08.
3. Smith V.C., Zupancic J.A., McCormick M.C., Croen L.A., Greene J., Escobar G.J., et al. Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. J Pediatr 2005, 146:469-473. Epub 2005/04/07.
4. Coalson J.J. Pathology of bronchopulmonary dysplasia. Semin Perinatol 2006, 30:179-184.
5. Philip A.G. Chronic lung disease of prematurity: a short history. Semin Fetal Neonatal Med 2009, 14:333-338.
6. Baraldi E., Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007, 357:1946-1955.
7. Bhandari A., Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics 2009, 123:1562-1573.
8. Bhandari V., Bizzarro M.J., Shetty A., Zhong X., Page G.P., Zhang H., et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006, 117:1901-1906.
9. Lavoie P.M., Pham C., Jang K.L. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 2008, 122:479-485.
10. Bhandari V., Gruen J.R. The genetics of bronchopulmonary dysplasia. Semin Perinatol 2006, 30:185-191.
11. Thompson A, V.B. Pulmonary biomarkers of bronchopulmonary dysplasia. Biomarker Insights 2008;3:361-73.
12. Bhandari A., Bhandari V. Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants. Front Biosci 2003, 8:e370-e380.
13. Ambalavanan N., Walsh M., Bobashev G., Das A., Levine B., Carlo W.A., et al. Intercenter differences in bronchopulmonary dysplasia or death among very low birth weight infants. Pediatrics 2011, 127:e106-e116. Epub 2010/12/15.
14. Srisuparp P., Marks J.D., Khoshnood B., Schreiber M.D. Predictive power of initial severity of pulmonary disease for subsequent development of bronchopulmonary dysplasia. Biol Neonate 2003, 84:31-36. Epub 2003/08/02.
15. Bhering C.A., Mochdece C.C., Moreira M.E., Rocco J.R., Sant'Anna G.M. Bronchopulmonary dysplasia prediction model for 7-day-old infants. J Pediatr (Rio J) 2007, 83:163-170. Epub 2007/03/24.
16. Cunha G.S., Mezzacappa-Filho F., Ribeiro J.D. Risk factors for bronchopulmonary dysplasia in very low birth weight newborns treated with mechanical ventilation in the first week of life. J Trop Pediatr 2005, 51:334-340. Epub 2005/06/02.
17. Oh W., Poindexter B.B., Perritt R., Lemons J.A., Bauer C.R., Ehrenkranz R.A., et al. Association between Fluid Intake and Weight Loss during the First Ten Days of Life and Risk of Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants. J Pediatr 2005, 147:786-790.
18. May C., Patel S., Kennedy C., Pollina E., Rafferty G.F., Peacock J.L., et al. Prediction of bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 2011, 96:F410-F416. Epub 2011/03/03.
19. Schmidt H.J., Bhandari V., Bhandari A., Davies J., Marshall B.C., Praud J.P., et al. The future in paediatric respirology. Respirology 2010.
20. Jelliffe-Pawlowski L.L., Shaw G.M., Stevenson D.K., Oehlert J.W., Quaintance C., Santos A.J., et al. Risk of bronchopulmonary dysplasia by second-trimester maternal serum levels of alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. Pediatr Res 2012, 71:399-406. Epub 2012/03/07.
21. Tsao P.N., Wei S.C., Su Y.N., Lee C.N., Chou H.C., Hsieh W.S., et al. Placenta growth factor elevation in the cord blood of premature neonates predicts poor pulmonary outcome. Pediatrics 2004, 113:1348-1351.
22. Janer J., Andersson S., Kajantie E., Lassus P. Endostatin concentration in cord plasma predicts the development of bronchopulmonary dysplasia in very low birth weight infants. Pediatrics 2009, 123:1142-1146. Epub 2009/04/02.
23. Mohamed W.A., Niyazy W.H., Mahfouz A.A. Angiopoietin-1 and endostatin levels in cord plasma predict the development of bronchopulmonary dysplasia in preterm infants. J Trop Pediatr 2011, 57:385-388. Epub 2010/12/07.
24. Borghesi A., Massa M., Campanelli R., Bollani L., Tzialla C., Figar T.A., et al. Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2009, 180:540-546. Epub 2009/07/04.
25. Baker C.D., Balasubramaniam V., Mourani P.M., Sontag M.K., Black C.P., Ryan B.S., et al. Cord blood angiogenic progenitor cells are decreased in bronchopulmonary dysplasia. Eur Respir J 2012, Epub 2012/04/13.
26. Joseph L., Nir A., Hammerman C., Goldberg S., Ben Shalom E., Picard E. N-terminal pro-B-type natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants. Am J Perinatol 2010, 27:381-386. Epub 2009/12/17.
27. Schrama A.J., Bernard A., Poorthuis B.J., Zwinderman A.H., Berger H.M., Walther F.J. Cord blood Clara cell protein CC16 predicts the development of bronchopulmonary dysplasia. Eur J Pediatr 2008, 167:1305-1312. Epub 2008/06/04.
28. Loughran-Fowlds A.S., Lin J.W., Oei J., Michalowski J., Henry R., Lui K. Early postnatal surge of serum Clara cell secretory protein in newborn infants. Neonatology 2012, 101:125-131. Epub 2011/09/29.
29. Sarafidis K., Stathopoulou T., Diamanti E., Soubasi V., Agakidis C., Balaska A., et al. Clara cell secretory protein (CC16) as a peripheral blood biomarker of lung injury in ventilated preterm neonates. Eur J Pediatr 2008, 167:1297-1303. Epub 2008/06/04.
30. Fukunaga S., Ichiyama T., Maeba S., Okuda M., Nakata M., Sugino N., et al. MMP-9 and TIMP-1 in the cord blood of premature infants developing BPD. Pediatr Pulmonol 2009, 44:267-272. Epub 2009/02/11.
31. Loughran-Fowlds A., Leach S., Lin J., Oei J., Henry R., Day A.S., et al. Respiratory disease and early serum S100A12 changes in very premature infants. Acta Paediatr 2011, 100:1538-1543. Epub 2011/06/16.
32. Kim D.H., Kim H.S., Shim S.Y., Lee J.A., Choi C.W., Kim E.K., et al. Cord blood KL-6, a specific lung injury marker, correlates with the subsequent development and severity of atypical bronchopulmonary dysplasia. Neonatology 2008, 93:223-229. Epub 2007/11/21.
33. Ogihara T., Hirano K., Morinobu T., Kim H.S., Ogawa S., Hiroi M., et al. Plasma KL-6 predicts the development and outcome of bronchopulmonary dysplasia. Pediatr Res 2006, 60:613-618. Epub 2006/09/22.
34. Vento G., Capoluongo E., Matassa P.G., Concolino P., Vendettuoli V., Vaccarella C., et al. Serum levels of seven cytokines in premature ventilated newborns: correlations with old and new forms of bronchopulmonary dysplasia. Intensive Care Med 2006, 32:723-730. Epub 2006/03/22.
35. Paananen R., Husa A.K., Vuolteenaho R., Herva R., Kaukola T., Hallman M. Blood cytokines during the perinatal period in very preterm infants: relationship of inflammatory response and bronchopulmonary dysplasia. J Pediatr 2009, 154:39-43. e3 Epub 2008/09/02.
36. Ambalavanan N., Carlo W.A., D'Angio C.T., McDonald S.A., Das A., Schendel D., et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 2009, 123:1132-1141.
37. Hogmalm A., Backstrom E., Bry M., Lappalainen U., Lukkarinen H.P., Bry K. Role of CXC Chemokine Receptor 2 in a Mouse Model of Bronchopulmonary Dysplasia. Am J Respir Cell Mol Biol 2012, Epub 2012/08/07.
38. Choo-Wing R., Nedrelow J.H., Homer R.J., Elias J.A., Bhandari V. Developmental differences in the responses of IL-6 and IL-13 transgenic mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 2007, 293:L142-L150.
39. Harijith A., Choo-Wing R., Cataltepe S., Yasumatsu R., Aghai Z.H., Janer J., et al. A role for matrix metalloproteinase 9 in IFNgamma-mediated injury in developing lungs: relevance to bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 2011, 44:621-630.
40. Sheikh S., Null D., Gentile D., Bimle C., Skoner D., McCoy K., et al. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants. Chest 2001, 119:1749-1754.
41. Bhandari V. Hyperoxia-derived lung damage in preterm infants. Semin Fetal Neonatal Med 2010.
42. Reuter S.D., O'Donovan D.J., Hegemier S.E., Smith E.O., Heird W.C., Fernandes C.J. Urinary F2-isoprostanes are poor prognostic indicators for the development of bronchopulmonary dysplasia. J Perinatol 2007, 27:303-306.
43. Joung K.E., Kim H.S., Lee J., Shim G.H., Choi C.W., Kim E.K., et al. Correlation of urinary inflammatory and oxidative stress markers in very low birth weight infants with subsequent development of bronchopulmonary dysplasia. Free radical research 2011, 45:1024-1032. Epub 2011/06/10.
44. Cullen A., Van Marter L.J., Allred E.N., Moore M., Parad R.B., Sunday M.E. Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia. Am J Respir Crit Care Med 2002, 165:1093-1097.
45. Subramaniam M., Bausch C., Twomey A., Andreeva S., Yoder B.A., Chang L., et al. Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2007, 176:902-912.
46. Bose C.L., Dammann C.E., Laughon M.M. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed 2008, 93:F455-F461. Epub 2008/08/05.
47. Aghai Z.H., Saslow J.G., Mody K., Eydelman R., Bhat V., Stahl G., et al. IFN-gamma and IP-10 in tracheal aspirates from premature infants: Relationship with bronchopulmonary dysplasia. Pediatr Pulmonol 2012, Epub 2012/03/21.
48. Kevill K.A., Bhandari V., Kettunen M., Leng L., Fan J., Mizue Y., et al. A role for macrophage migration inhibitory factor in the neonatal respiratory distress syndrome. J Immunol 2008, 180:601-608.
49. Knaapi J., Lukkarinen H., Kiviranta R., Steiner A., Lassus P., Andersson S., et al. Cathepsin K expression is diminished in infants with bronchopulmonary dysplasia. Acta Paediatr 2006, 95:1298-1300.
50. Sohn M.H., Kang M.J., Matsuura H., Bhandari V., Chen N.Y., Lee C.G., et al. The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 2010, 182:918-928. Epub 2010/06/19.
51. Li Z., Choo-Wing R., Sun H., Sureshbabu A., Sakurai R., Rehan V.K., et al. A potential role of the JNK pathway in hyperoxia-induced cell death, myofibroblast transdifferentiation and TGF-beta1-mediated injury in the developing murine lung. BMC cell biology 2011, 12:54. Epub 2011/12/17.
52. Hasan J., Beharry K.D., Valencia A.M., Strauss A., Modanlou H.D. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Pediatrics 2009, 123:1541-1547. Epub 2009/06/02.
53. Meller S., Bhandari V. VEGF levels in humans and animal models with RDS and BPD: temporal relationships. Experimental lung research 2012, 38:192-203. Epub 2012/03/08.
54. Bhandari V., Choo-Wing R., Lee C.G., Yusuf K., Nedrelow J.H., Ambalavanan N., et al. Developmental regulation of NO-mediated VEGF-induced effects in the lung. Am J Respir Cell Mol Biol 2008, 39:420-430.
55. Janer J., Andersson S., Haglund C., Karikoski R., Lassus P. Placental growth factor and vascular endothelial growth factor receptor-2 in human lung development. Pediatrics 2008, 122:340-346. Epub 2008/08/05.
56. De Paepe M.E., Patel C., Tsai A., Gundavarapu S., Mao Q. Endoglin (CD105) Upregulation in Pulmonary Microvasculature of Ventilated Preterm Infants. Am J Respir Crit Care Med 2008.
57. Davis C.W., Gonzales L.W., Ballard R.A., Ballard P.L., Guo C., Gow A.J. Expression of nitric oxide synthases and endogenous NO metabolism in bronchopulmonary dysplasia. Pediatr Pulmonol 2008, 43:703-709. Epub 2008/05/27.
58. Aghai Z.H., Faqiri S., Saslow J.G., Nakhla T., Farhath S., Kumar A., et al. Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone. J Perinatol 2008, 28:149-155.
59. Bhandari V., Choo-Wing R., Lee C.G., Zhu Z., Nedrelow J.H., Chupp G.L., et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006, 12:1286-1293.
60. Rudiger M., von Baehr A., Haupt R., Wauer R.R., Rustow B. Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often. Crit Care Med 2000, 28:1572-1577. Epub 2000/06/02.
61. Capoluongo E., Vento G., Lulli P., Di Stasio E., Porzio S., Vendettuoli V., et al. Epithelial lining fluid neutrophil-gelatinase-associated lipocalin levels in premature newborns with bronchopulmonary dysplasia and patency of ductus arteriosus. International journal of immunopathology and pharmacology 2008, 21:173-179. Epub 2008/03/14.
62. Farhath S., He Z., Nakhla T., Saslow J., Soundar S., Camacho J., et al. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatrics 2008, 121:e253-e259. Epub 2008/02/05.
63. Hikino S., Ohga S., Kinjo T., Kusuda T., Ochiai M., Inoue H., et al. Tracheal aspirate gene expression in preterm newborns and development of bronchopulmonary dysplasia. Pediatr Int 2012, 54:208-214. Epub 2011/11/10.
64. Mody K., Saslow J.G., Kathiravan S., Eydelman R., Bhat V., Stahl G.E., et al. Sirtuin1 in tracheal aspirate leukocytes: possible role in the development of bronchopulmonary dysplasia in premature infants. J Matern Fetal Neonatal Med 2012, 25:1483-1487. Epub 2012/01/26.
65. Bhattacharya S., Go D., Krenitsky D.L., Huyck H.L., Solleti S.K., Lunger V.A., et al. Genome-wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2012, 186:349-358. Epub 2012/06/23.
66. McGowan E.C., Kostadinov S., McLean K., Gotsch F., Venturini D., Romero R., et al. Placental IL-10 dysregulation and association with bronchopulmonary dysplasia risk. Pediatr Res 2009, 66:455-460. Epub 2009/07/08.
67. De Felice C., Parrini S., Barducci A., Chitano G., Tonni G., Latini G. Abnormal oral mucosal light reflectance in bronchopulmonary dysplasia. Early Hum Dev 2006, 82:273-278. Epub 2005/12/13.
68. May C., Williams O., Milner A.D., Peacock J., Rafferty G.F., Hannam S., et al. Relation of exhaled nitric oxide levels to development of bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 2009, 94:F205-F209. Epub 2009/04/23.
69. Oue S., Hiroi M., Ogawa S., Hira S., Hasegawa M., Yamaoka S., et al. Association of gastric fluid microbes at birth with severe bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 2009, 94:F17-F22. Epub 2008/08/05.
70. De Felice C., Latini G., Del Vecchio A., Toti P., Bagnoli F., Petraglia F. Small thymus at birth: a predictive radiographic sign of bronchopulmonary dysplasia. Pediatrics 2002, 110:386-388. Epub 2002/08/08.
71. Lavoie P.M., Dube M.P. Genetics of bronchopulmonary dysplasia in the age of genomics. Curr Opin Pediatr 2010, 22:134-138. Epub 2010/01/21.
72. Cohen J., Van Marter L.J., Sun Y., Allred E., Leviton A., Kohane I.S. Perturbation of gene expression of the chromatin remodeling pathway in premature newborns at risk for bronchopulmonary dysplasia. Genome biology 2007, 8:R210. Epub 2007/10/06.
73. de Felice C., Latini G., Parrini S., Bianciardi G., Toti P., Kopotic R.J., et al. Oral mucosal microvascular abnormalities: an early marker of bronchopulmonary dysplasia. Pediatr Res 2004, 56:927-931.